Lisa S Chen, Prithviraj Bose, Wei Qiao, Yongying Jiang, Qi Wu, Nichole D Cruz, Michael J Keating, Varsha Gandhi
{"title":"A pilot study of lower doses of ibrutinib: patient body weight does not correlate with plasma ibrutinib levels during therapy.","authors":"Lisa S Chen, Prithviraj Bose, Wei Qiao, Yongying Jiang, Qi Wu, Nichole D Cruz, Michael J Keating, Varsha Gandhi","doi":"10.1080/10428194.2025.2461672","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":" ","pages":"1-3"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2025.2461672","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor